iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionBotty Investors LLC
Latest Disclosed Ownership16,750 shares
Latest Disclosed Value $ 2,828,238
Botty Investors LLC ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On May 14, 2026 - Botty Investors LLC filed a 13F-HR form disclosing ownership of 16,750 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $2,828,238 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 16,750 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.00% during the quarter. The current value of the position is $2,195,088 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 16,750 0 0.00 2,828 0.07 0.6733
2026-02-13 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 16,750 0 0.00 2,827 16.87 0.6704
2025-11-12 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 16,750 0 0.00 2,418 14.11 0.6634
2025-08-13 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 16,750 0 0.00 2,119 -1.07 0.6226
2025-05-15 2025-03-31 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 16,750 750 4.69 2,142 1.28 0.7044
2025-05-14 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 16,750 750 2,142 0.7288
2025-02-13 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 16,000 -750 -4.48 2,115 -13.25 0.6949
2024-11-13 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 16,750 0 0.00 2,439 6.05 0.8147
2024-08-13 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 16,750 0 0.00 2,299 0.04 0.8633
2024-05-14 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 16,750 16,750 2,298 0.9594
2020-07-31 2020-06-30 13F Nasdaq Biotech ETF IV COM 464287556 0 -6,180 -100.00 0 -100.00
2020-05-13 2020-03-31 13F Nasdaq Biotech ETF IV COM 464287556 6,180 -960 -13.45 666 -22.56 0.2625
2020-02-12 2019-12-31 13F Nasdaq Biotech ETF IV COM 464287556 7,140 -495 -6.48 860 13.16 0.2629
2019-11-13 2019-09-30 13F Nasdaq Biotech ETF IV COM 464287556 7,635 -300 -3.78 760 -12.24 0.2571
2019-07-26 2019-06-30 13F Nasdaq Biotech ETF IV COM 464287556 7,935 -22,200 -73.67 866 -74.30 0.2740
2019-05-10 2019-03-31 13F Nasdaq Biotech ETF IV COM 464287556 30,135 -138 -0.46 3,369 15.42 1.0072
2019-02-14 2018-12-31 13F Nasdaq Biotech ETF IV COM 464287556 30,273 -34,800 -53.48 2,919 -63.22 1.0129
2018-10-24 2018-09-30 13F iShares Nasdaq Biotechnology ETF IV COM 464287556 65,073 0 0.00 7,937 10.91 2.1578
2018-08-14 2018-06-30 13F iShares Nasdaq Biotechnology ETF IV COM 464287556 65,073 0 0.00 7,156 3.02 2.0617
2018-05-14 2018-03-31 13F/A-1 iShares Nasdaq Biotechnology ETF IV COM 464287556 65,073 0 0.00 6,946 -0.03 2.0477
2018-05-14 2018-03-31 13F iShares Nasdaq Biotechnology ETF IV COM 464287556 65,073 0 6,948
2018-02-14 2017-12-31 13F iShares Nasdaq Biotechnology ETF IV COM 464287556 65,073 43,382 200.00 6,948 -3.98 2.1678
2017-11-14 2017-09-30 13F iShares Nasdaq Biotechnology ETF IV COM 464287556 21,691 0 0.00 7,236 7.58 2.3050
2017-08-03 2017-06-30 13F iShares Nasdaq Biotechnology ETF IV COM 464287556 21,691 -2,364 -9.83 6,726 -4.65 2.1424
2017-05-12 2017-03-31 13F iShares Nasdaq Biotechnology ETF IV COM 464287556 24,055 120 0.50 7,054 11.05 2.6502
2017-02-14 2016-12-31 13F Ishares Nasdaq Biotech Indx COM 464287556 23,935 13,450 128.28 6,352 109.29 3.7365
2016-11-09 2016-09-30 13F Ishares Nasdaq Biotech Indx COM 464287556 10,485 10,000 2,061.86 3,035 2,328.00 1.7339
2016-07-21 2016-06-30 13F Ishares Nasdaq Biotech Indx COM 464287556 485 0 0.00 125 -0.79 0.0713
2016-05-10 2016-03-31 13F Ishares Nasdaq Biotech Indx COM 464287556 485 75 18.29 126 -9.35 0.0690
2016-02-12 2015-12-31 13F Ishares Nasdaq Biotech Indx COM 464287556 410 410 139 0.0978
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.